266 related articles for article (PubMed ID: 22393379)
1. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis.
Solís García del Pozo J; Solera J
PLoS One; 2012; 7(2):e32090. PubMed ID: 22393379
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials.
Skalsky K; Yahav D; Bishara J; Pitlik S; Leibovici L; Paul M
BMJ; 2008 Mar; 336(7646):701-4. PubMed ID: 18321957
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics for treating human brucellosis.
Yousefi-Nooraie R; Mortaz-Hejri S; Mehrani M; Sadeghipour P
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007179. PubMed ID: 23076931
[TBL] [Abstract][Full Text] [Related]
4. Treatment of brucellosis: a systematic review of studies in recent twenty years.
Alavi SM; Alavi L
Caspian J Intern Med; 2013; 4(2):636-41. PubMed ID: 24009951
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].
Alp E; Koc RK; Durak AC; Yildiz O; Aygen B; Sumerkan B; Doganay M
BMC Infect Dis; 2006 Apr; 6():72. PubMed ID: 16606473
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
Sofian M; Velayati AA; Aghakhani A; McFarland W; Farazi AA; Banifazl M; Eslamifar A; Ramezani A
Scand J Infect Dis; 2014 Aug; 46(8):573-7. PubMed ID: 24934986
[TBL] [Abstract][Full Text] [Related]
7. Update on treatment options for spinal brucellosis.
Ulu-Kilic A; Karakas A; Erdem H; Turker T; Inal AS; Ak O; Turan H; Kazak E; Inan A; Duygu F; Demiraslan H; Kader C; Sener A; Dayan S; Deveci O; Tekin R; Saltoglu N; Aydın M; Horasan ES; Gul HC; Ceylan B; Kadanalı A; Karabay O; Karagoz G; Kayabas U; Turhan V; Engin D; Gulsun S; Elaldı N; Alabay S
Clin Microbiol Infect; 2014 Feb; 20(2):O75-82. PubMed ID: 24118178
[TBL] [Abstract][Full Text] [Related]
8. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.
Bayindir Y; Sonmez E; Aladag A; Buyukberber N
J Chemother; 2003 Oct; 15(5):466-71. PubMed ID: 14598939
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
[TBL] [Abstract][Full Text] [Related]
10. Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study.
Al-Madfaa RO; Alalawi MA; Basudan LO; Alhejaili SF; Eljaaly K; Madani TA; Thabit AK
J Infect Dev Ctries; 2020 Dec; 14(12):1380-1386. PubMed ID: 33378279
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial.
Roushan MR; Amiri MJ; Janmohammadi N; Hadad MS; Javanian M; Baiani M; Bijani A
J Antimicrob Chemother; 2010 May; 65(5):1028-35. PubMed ID: 20215128
[TBL] [Abstract][Full Text] [Related]
12. Persistence and relapse in brucellosis and need for improved treatment.
Franco MP; Mulder M; Smits HL
Trans R Soc Trop Med Hyg; 2007 Sep; 101(9):854-5. PubMed ID: 17604065
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin versus streptomycin for brucellosis treatment in humans: A meta-analysis of randomized controlled trials.
Meng F; Pan X; Tong W
PLoS One; 2018; 13(2):e0191993. PubMed ID: 29462155
[TBL] [Abstract][Full Text] [Related]
14. Doxycycline-rifampicin: physicians' inferior choice in brucellosis or how convenience reigns over science.
Pappas G; Siozopoulou V; Akritidis N; Falagas ME
J Infect; 2007 May; 54(5):459-62. PubMed ID: 17070921
[TBL] [Abstract][Full Text] [Related]
15. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Karabay O; Sencan I; Kayas D; Sahin I
BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations and treatment outcomes of human brucellosis at a tertiary care center in Saudi Arabia.
Edathodu J; Alamri M; Alshangiti KA; Alfagyh NS; Alnaghmush AS; Albaiz F; Alothman B; Khalil H; Edathodu Z; Alrajhi AA
Ann Saudi Med; 2021; 41(2):109-114. PubMed ID: 33818142
[TBL] [Abstract][Full Text] [Related]
17. [Meta-analysis of the efficacy of the combination of +rifampicin and doxycycline in the treatment of human brucellosis].
Solera J; Martínez-Alfaro E; Sáez L
Med Clin (Barc); 1994 May; 102(19):731-8. PubMed ID: 8041202
[TBL] [Abstract][Full Text] [Related]
18. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.
Colmenero Castillo JD; Hernandez Marquez S; Reguera Iglesias JM; Cabrera Franquelo F; Rius Diaz F; Alonso A
Chemotherapy; 1989; 35(2):146-52. PubMed ID: 2667903
[TBL] [Abstract][Full Text] [Related]
19. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis.
Roushan MR; Gangi SM; Ahmadi SA
Swiss Med Wkly; 2004 Sep; 134(37-38):564-8. PubMed ID: 15551160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
